Cargando…

Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy

INTRODUCTION: Membranous nephropathy (MN) is the most common glomerular disease associated with sarcoidosis. The target antigen M-type phospholipase A2 receptor 1 (PLA2R) has been identified in a subset of sarcoidosis-associated MN. The target antigen is not known in the remaining sarcoidosis-associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zubidat, Dalia, Madden, Benjamin, Kudose, Satoru, Nasr, Samih H., Nardelli, Luca, Fervenza, Fernando C., Sethi, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239775/ https://www.ncbi.nlm.nih.gov/pubmed/37284677 http://dx.doi.org/10.1016/j.ekir.2023.03.019

Ejemplares similares

Proteomic Analysis of Complement Proteins in Membranous Nephropathy
por: Ravindran, Aishwarya, et al.
Publicado: (2020)

The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy
por: Bu, Lihong, et al.
Publicado: (2023)

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
por: Stefan, Gabriel, et al.
Publicado: (2022)

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations
por: Sethi, Sanjeev, et al.
Publicado: (2014)

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy
por: Hladunewich, Michelle A., et al.
Publicado: (2014)

An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression
por: Zand, Ladan, et al.
Publicado: (2019)

Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy
por: Kudose, Satoru, et al.
Publicado: (2023)

Segmental NELL-1 Membranous Nephropathy Complicating Tiopronin Therapy
por: Santoriello, Dominick, et al.
Publicado: (2023)

Immune-Complex Glomerulonephritis After COVID-19 Infection
por: Sethi, Sanjeev, et al.
Publicado: (2021)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

Atypical Antiglomerular Basement Membrane Nephritis Following Immune Checkpoint Inhibitor
por: Javaugue, Vincent, et al.
Publicado: (2022)

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

Future landscape for the management of membranous nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Novel Treatments Paradigms: Membranous Nephropathy
por: Rojas-Rivera, Jorge E., et al.
Publicado: (2023)

“Precision” Medicine in Membranous Nephropathy: Serology-Guided Therapy
por: Glassock, Richard J., et al.
Publicado: (2023)

Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
por: Rojas-Rivera, Jorge, et al.
Publicado: (2021)

Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series
por: Ravindran, Aishwarya, et al.
Publicado: (2022)

Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023)

Atypical post-infectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosis
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
por: Zand, Ladan, et al.
Publicado: (2021)

C3 Glomerulonephritis: Clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up
por: Sethi, Sanjeev, et al.
Publicado: (2012)

COVID-19 Vaccination and Glomerulonephritis
por: Klomjit, Nattawat, et al.
Publicado: (2021)

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
por: Sethi, Supreet, et al.
Publicado: (2020)

Membranous nephropathy: a single disease or a pattern of injury resulting from different diseases
por: Sethi, Sanjeev
Publicado: (2021)

Membranous nephropathy in a patient with coronavirus disease 2019 (COVID-19): A case report
por: Miao, Jing, et al.
Publicado: (2021)

Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy
por: Kudose, Satoru, et al.
Publicado: (2021)

C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome
por: Bobart, Shane A., et al.
Publicado: (2019)

The presence of mycobacterial antigens in sarcoidosis associated granulomas
por: Shamaei, Masoud, et al.
Publicado: (2017)

The Antigenic Landscape of Pediatric Membranous Nephropathy
por: Kurien, Anila Abraham, et al.
Publicado: (2023)

Pauci-immune Crescentic Glomerulonephritis Due to MGRS Crystalline Nephropathy
por: Sharma, Shailendra, et al.
Publicado: (2019)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
por: Fervenza, Fernando C, et al.
Publicado: (2008)

Histiocytic glomerulopathy associated with macrophage activation syndrome
por: Eirin, Alfonso, et al.
Publicado: (2015)

Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2021)

Pediatric membranous nephropathy: In the novel antigens era
por: Huang, Guoping, et al.
Publicado: (2022)

Fever, splenomegaly and lymphopenia in sarcoidosis
por: Ravaglia, Claudia, et al.
Publicado: (2013)

Profile of Indian Patients With Membranous Nephropathy
por: Subramanian, Priyadarsani, et al.
Publicado: (2020)

Leishmaniasis-Associated Membranoproliferative Glomerulonephritis With Massive Complement Deposition
por: Sethi, Sanjeev, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l0ln976schp78uk00eqamgbhpm